http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22033814

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, P.H.S.
endingPage 155
issn 1389-0344
issueIdentifier 6
pageRange 145-155
publicationName Biomolecular Engineering
startingPage 145
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_50cd1567c8c6f7b98a0795639f106938
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5adaa4a6c7e07862a96d3a3fe5f1c42d
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ae85d20ba2bb783bdba6606cc1eac964
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_93ac2670878e23ce6931dbba621c635e
bibliographicCitation Asai T, Trinh R, Ng PP, Penichet ML, Wims LA, Morrison SL. A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery. Biomol Eng. 2005 Feb;21(6):145–55. doi: 10.1016/j.bioeng.2004.10.001. PMID: 15748688.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8042d13690b803424a57cf1c0b76ecd5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fbfb9950990bb6ba570f5242f7ba4e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b81d26490ca900760099f1b740a37f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c97f4c834d576ccf37b918008a56b370
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acdfa567c63db08bbdaff8dba5891e1b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_702ac3dca1b1b9efd1adde0de6b4a720
date 200502
identifier https://doi.org/10.1016/j.bioeng.2004.10.001
https://pubmed.ncbi.nlm.nih.gov/15748688
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21712
https://portal.issn.org/resource/ISSN/1389-0344
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery
discusses http://id.nlm.nih.gov/mesh/M0002565
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0376295
http://id.nlm.nih.gov/mesh/M0018164
http://id.nlm.nih.gov/mesh/M0018640
http://id.nlm.nih.gov/mesh/M0002040
http://id.nlm.nih.gov/mesh/M0017642
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015202Q000379
http://id.nlm.nih.gov/mesh/D011683Q000235
http://id.nlm.nih.gov/mesh/D011355Q000008
http://id.nlm.nih.gov/mesh/D016503Q000379
http://id.nlm.nih.gov/mesh/D001360Q000235
http://id.nlm.nih.gov/mesh/D009101Q000188
http://id.nlm.nih.gov/mesh/D007074Q000235
http://id.nlm.nih.gov/mesh/D011683Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001710Q000235
http://id.nlm.nih.gov/mesh/D007074Q000378
http://id.nlm.nih.gov/mesh/D007074Q000276
http://id.nlm.nih.gov/mesh/D001360Q000378
http://id.nlm.nih.gov/mesh/D011683Q000378
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D001710Q000276
http://id.nlm.nih.gov/mesh/D001710Q000378
http://id.nlm.nih.gov/mesh/D011485
http://id.nlm.nih.gov/mesh/D011355Q000378
http://id.nlm.nih.gov/mesh/D004926Q000378
http://id.nlm.nih.gov/mesh/D004926Q000235
http://id.nlm.nih.gov/mesh/D011993Q000378
http://id.nlm.nih.gov/mesh/D017434
http://id.nlm.nih.gov/mesh/D001360Q000276
http://id.nlm.nih.gov/mesh/D011993Q000008
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D000918Q000235
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_6.4.1.3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6223f68762a790ba1a86ab3d4f03c54d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92753
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_dd659348c317942ce6b00831656a1703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.4.1

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128843944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129729175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129771248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135852020

Total number of triples: 83.